Question 1

What is Yervoy?

Accepted Answer

Yervoy is a monoclonal antibody that functions as a type of immunotherapy. It works by targeting a specific protein to help the immune system recognize and attack cancer cells.

By blocking this protein, the medication allows the body's natural defenses to more effectively identify and destroy malignant cells.

Question 2

What is Yervoy used for?

Accepted Answer

Yervoy is used to treat the following conditions:

Colorectal cancer

Hepatocellular carcinoma

Malignant pleural mesothelioma

Others

Question 3

How does Yervoy work?

Accepted Answer

Mechanism of Action

Yervoy belongs to a class of drugs known as monoclonal antibodies. Specifically, it is a type of immunotherapy called a checkpoint inhibitor. It works by targeting a specific protein in the body called CTLA-4 (cytotoxic T-lymphocyte-associated protein 4).

The immune system uses checkpoints like CTLA-4 to keep immune responses in check and prevent the body from attacking its own healthy cells. However, some cancer cells can use these checkpoints to hide from the immune system.

Yervoy works by:

Blocking the off switch: By binding to CTLA-4, the medication prevents this protein from sending a signal to turn off the immune response.

Activating T-cells: Removing this brake allows T-cells, a type of white blood cell, to remain active and multiply.

Targeting cancer: These activated T-cells are then better able to identify, reach, and destroy cancer cells throughout the body.

Because Yervoy stimulates the immune system generally, it may also cause the immune system to attack normal, healthy tissues in any part of the body.

Question 4

What are the active ingredients in Yervoy?

Accepted Answer

The active ingredient in Yervoy is ipilimumab .

Question 5

What are the side effects of Yervoy?

Accepted Answer

Common side effects of Yervoy may include:

fatigue

diarrhea

rash

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Yervoy?

Accepted Answer

Yervoy belongs to the immune checkpoint inhibitor drug class.

Question 7

What is the dosage of Yervoy and how do I take it?

Accepted Answer

Administration

Yervoy is delivered directly into a vein through an intravenous (IV) infusion. This procedure must be performed by a healthcare professional in a hospital or clinic environment. The infusion process typically takes a set amount of time, often lasting between 30 and 90 minutes.

Treatment Frequency

The schedule for receiving this medication depends on the specific condition being treated and whether it is being used alone or in combination with other therapies. It is generally administered in cycles, which involve receiving the medication followed by a rest period. Your healthcare team will monitor your progress and determine the total number of treatments required.

Missed Dose

If you miss an appointment for your infusion, contact your healthcare provider immediately to reschedule. It is important to receive each dose as scheduled to ensure the medication works effectively. Your doctor will provide guidance on how to get back on track with your treatment plan.

Question 8

Is Yervoy safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Yervoy can cause harm to an unborn baby. Research indicates that this medication may increase the risk of pregnancy loss or cause the immune system to attack the fetus. Patients should inform their healthcare provider if they are pregnant or planning to become pregnant before starting treatment.

Contraception

Individuals who can become pregnant are advised to use effective birth control during treatment with Yervoy. To ensure the medication has cleared the system, effective contraception should be continued for at least 3 months after the final dose. If a pregnancy occurs during treatment, it should be reported to a healthcare provider immediately.

Breastfeeding

It is not known if Yervoy passes into human breast milk. Because of the potential for serious adverse reactions in a nursing infant, breastfeeding is not recommended during treatment and for 3 months after the last dose.

Question 9

What forms and strengths does Yervoy come in?

Accepted Answer

Yervoy is supplied as a sterile liquid solution for intravenous administration. It is administered as an infusion into a vein by a healthcare professional.

Intravenous solution

The medication is provided in vials and must be prepared and diluted by a medical provider before use.

Question 10

What is the FDA approval status of Yervoy?

Accepted Answer

FDA Approval History

Yervoy (ipilimumab) received its initial FDA approval in 2011 for the treatment of unresectable or metastatic melanoma. It was the first therapy shown to improve overall survival in patients with advanced melanoma. Over the following decade, its regulatory status expanded to include several other oncology indications, often in combination with other immunotherapies.

Approved Indications

The FDA has approved Yervoy for several specific uses, including:

Melanoma: Treatment of unresectable or metastatic melanoma in adults and pediatric patients, and as adjuvant treatment for certain melanoma patients.

Renal Cell Carcinoma: In combination with nivolumab for patients with intermediate or poor-risk, previously untreated advanced renal cell carcinoma.

Colorectal Cancer: In combination with nivolumab for certain patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer.

Hepatocellular Carcinoma: In combination with nivolumab for patients with liver cancer previously treated with sorafenib.

Lung Cancer: In combination with nivolumab for certain types of metastatic non-small cell lung cancer.

Pleural Mesothelioma: As a first-line treatment in combination with nivolumab for adults with unresectable malignant pleural mesothelioma.

Boxed Warning

The FDA requires a boxed warning for Yervoy due to the risk of severe and fatal immune-mediated adverse reactions. These reactions result from the drug's effect on the immune system, which can cause it to attack healthy tissues. Common sites for these reactions include the intestines (colitis), liver (hepatitis), skin (dermatitis), and endocrine glands (endocrinopathies). Early identification and management of these symptoms are critical for patient safety.

Question 11

What should I know about Yervoy and cost?

Accepted Answer

Estimated Pricing

Yervoy is a specialized biologic medication administered by intravenous infusion. The approximate cost for a 50 mg/10 mL vial is $8,411, while a 200 mg/40 mL vial is approximately $33,643. These prices are for the medication only and do not include additional costs for the infusion procedure, hospital fees, or laboratory monitoring.

Insurance Coverage

Most insurance plans, including Medicare and Medicaid, provide coverage for Yervoy when it is used for FDA-approved indications. Because it is administered in a doctor's office or clinic, it is usually processed through a patient's medical insurance rather than a prescription drug plan. Out-of-pocket costs like deductibles and coinsurance will vary by plan.

Financial Assistance

The manufacturer may offer support programs to help reduce costs for eligible patients. These options often include:

Copay assistance for patients with private or commercial insurance.

Patient assistance programs that provide the medication at no cost to those who meet specific financial and insurance criteria.

Generic Availability

There is currently no generic or biosimilar version of Yervoy available. It is only sold as a brand-name product.

Yervoy

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?